Matt Outten Email & Phone Number
Chief Executive Officer at QED Therapeutics Oncology and Chief Commercial Officer at BridgeBio @ BridgeBio
5 free lookup(s).
If you need more lookups,
subscriptions start at $34 USD/month.
Matt Outten Location
- California, United States
Matt Outten Work
- 2019 -now Chief Executive Officer at QED Therapeutics Oncology and Chief Commercial Officer at BridgeBio @
- 2018 -2019 Chief Commercial Officer @ QED Therapeutics, a BridgeBio Company
- 2015 -2018 Vice President of Marketing and Market Access @
- 2014 -2015 Head of Market Access and Commercial Liaison @
- 2014 -2014 Vice President Commercial Operations and Interim CCO @
- 2013 -2014 Executive Director Market Access and Senior Director Market Access @
- 2010 -2013 Director Managed Markets @
- 2008 -2010 Associate Director of Reimbursement Strategy and National Accounts @
- 2007 -2008 US Managed Markets Senior Product Manager - Virology, Oncology, CNS, and New Product Development @
- 2006 -2007 US Managed Markets Product Manager Virology and Oncology @
- 2005 -2006 US Marketing Product Manager Virology @
- 2004 -2005 Virology Biologic Specialty Sales Representative @
- 2002 -2004 Neurohealth Specialty Sales Representative @
- 2001 -2002 Pharmaceutical Sales Representative and Field Trainer @
Matt Outten Education
- Harvard University
- Hamilton College
- University of Delaware
- The Hill School
Matt Outten Skills
- Leadership
- Co Promotions
- In Line
- Patient Assistance Program Creation
- P&L Accountability
- Cross Functional Team
- Cardiology
- New Indication Launch
- Sales
- Rebate And Pricing Structuring
- Gastroenterology
- Neurology
- Pipeline Strategy Development
- Gross To Net Management
- Clinical Research
- Pharmacy Benefit
- Biotechnology
- Virology
- Healthcare
- Investor Relations
- Medical Devices
- Strategic Planning
- Strategy
- Operations
- Microsoft Office
- Distributor Network Formation
- Budget Administration
- Personnel Recruitment
- Negotiations
- Operations Management
- Pharmacoeconomic Modeling
- Oncology
- Marketing
- Payer Marketing Strategies
- Cross Functional Team Leadership
- Managed Care
- Pharmacy Benefit Management
- Specialty Pharmacy
- Diabetes
- Implementation
- Product Launch
- Due Diligence
- Pharmaceutical Industry
- Strategic Alliances
- Pharmaceutical Sales
- Organizational Leadership
- Market Access
- Mergers and Acquisitions
- Organizational
- Market Access Strategy Development
- Hospitals
- Change Management
Matt Outten Summary
- Matt Outten, based in California, United States, is currently a Chief Executive Officer at QED Therapeutics Oncology and Chief Commercial Officer at BridgeBio at BridgeBio. Matt Outten brings experience from previous roles at QED Therapeutics, a BridgeBio Company and Pharmacyclics. Matt Outten holds a Harvard University. With a robust skill set that includes Leadership, Co Promotions, In Line, Patient Assistance Program Creation, P&L Accountability and more. Matt Outten has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Matt Outten?
Find contact details for 700 million professionals.
Others Named Matt Outten
Matthew Outten
Training Specialist
Waynesville, MO, US
Matthew Outten
Surveyor
Perth, WA, AU
Top BridgeBio Employees
Bubba Murarka
Executive Vice President
California, United States
Clayton Beard
CSO and Site Head, Gene Therapy
Chapel Hill, NC, US
Neil Kumar
CEO and Founder
California, United States
Rick Panicucci
Chief Technology Officer of CMC
Hilton Head Island, SC, US
Scott Collins
Senior Vice President - Head of Market Access - BridgeBio
San Francisco, CA, US
Ted Lystig
SVP, Chief Analytics Officer
Huntsville, UT, US
Christine Siu
Chief Executive Officer, ML Bio Solutions
California, United States
Thomas Trimarchi
President and Chief Financial Officer
United States
Sun-Gou Ji
Vice President, Computational Genomics
Boston, MA, US
Jesper Jernelius
Chief Technical Officer
San Francisco, CA, US
Leonid Katz
Chief Development Officer, Cardiovascular
California, United States
Adam Shaywitz
Chief Medical Officer, Gene Therapy
Los Angeles, CA, US
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
California, United States
Adora Ndu
Chief Regulatory Officer
Washington, DC, US
Josh Loehrer
Chief Operating Officer, Cardiovascular
California, United States
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co